Related references
Note: Only part of the references are listed.A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
J. A. Regules et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Preventing Cleavage of the Respiratory Syncytial Virus Attachment Protein in Vero Cells Rescues the Infectivity of Progeny Virus for Primary Human Airway Cultures
Jacqueline Corry et al.
JOURNAL OF VIROLOGY (2016)
Teicoplanin inhibits Ebola pseudovirus infection in cell culture
Yizhuo Wang et al.
ANTIVIRAL RESEARCH (2016)
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
K. Ewer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Antimicrobial Peptide LL-37 Is Both a Substrate of Cathepsins S and K and a Selective Inhibitor of Cathepsin L
Pierre-Marie Andrault et al.
BIOCHEMISTRY (2015)
Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry
Aileen O'Hearn et al.
JOURNAL OF VIROLOGY (2015)
Ebola Virus and Severe Acute Respiratory Syndrome Coronavirus Display Late Cell Entry Kinetics: Evidence that Transport to NPC1+ Endolysosomes Is a Rate-Defining Step
Rebecca M. Mingo et al.
JOURNAL OF VIROLOGY (2015)
Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: Synthesis and antiviral studies
Ilona Bereczki et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry
Gerrit Gehring et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
A Novel Life Cycle Modeling System for Ebola Virus Shows a Genome Length-Dependent Role of VP24 in Virus Infectivity
Ari Watt et al.
JOURNAL OF VIROLOGY (2014)
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Xiangguo Qiu et al.
NATURE (2014)
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
Travis K. Warren et al.
NATURE (2014)
Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2
Kazuya Shirato et al.
JOURNAL OF VIROLOGY (2013)
The HOPS Proteins hVps41 and hVps39 Are Required for Homotypic and Heterotypic Late Endosome Fusion
Maaike S. Pols et al.
TRAFFIC (2013)
Teicoplanin therapy leading to a significant decrease in viral load in a patient with chronic hepatitis C
Andreas Maieron et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
An Analogue of the Antibiotic Teicoplanin Prevents Flavivirus Entry In Vitro
Tine De Burghgraeve et al.
PLOS ONE (2012)
Molecular architecture of the multisubunit homotypic fusion and vacuole protein sorting (HOPS) tethering complex
Cornelia Broecker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibiotics
Susan Obeid et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection
Marceline Cote et al.
NATURE (2011)
Ebola virus entry requires the cholesterol transporter Niemann-Pick C1
Jan E. Carette et al.
NATURE (2011)
T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus
Andrew S. Kondratowicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
Thomas W. Geisbert et al.
LANCET (2010)
A broad-spectrum antiviral targeting entry of enveloped viruses
Mike C. Wolf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes
Mohammad F. Saeed et al.
PLOS PATHOGENS (2010)
Ebolavirus Is Internalized into Host Cells via Macropinocytosis in a Viral Glycoprotein-Dependent Manner
Asuka Nanbo et al.
PLOS PATHOGENS (2010)
Newly Discovered Ebola Virus Associated with Hemorrhagic Fever Outbreak in Uganda
Jonathan S. Towner et al.
PLOS PATHOGENS (2008)
Tyro3 family-mediated cell entry of Ebola and Marburg viruses
Masayuki Shimojima et al.
JOURNAL OF VIROLOGY (2006)
Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics
Jan Balzarini et al.
ANTIVIRAL RESEARCH (2006)
Polycyclic peptide and glycopeptide antibiotics and their derivatives as inhibitors of HIV entry
Maria N. Preobrazhenskaya et al.
ANTIVIRAL RESEARCH (2006)
LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus
T Gramberg et al.
VIROLOGY (2005)
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
G Simmons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection
K Chandran et al.
SCIENCE (2005)
Pathogenesis of Ebola hemorrhagic fever in primate models - Evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells
TW Geisbert et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
Antiretroviral activity of semisynthetic derivatives of glycopeptide antibiotics
J Balzarini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells
DH Ebert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans
CP Alvarez et al.
JOURNAL OF VIROLOGY (2002)
Folate receptor-α is a cofactor for cellular entry by Marburg and Ebola viruses
SY Chan et al.
CELL (2001)
Downregulation of β1 integrins by Ebola virus glycoprotein:: Implication for virus entry
A Takada et al.
VIROLOGY (2000)
A Ypt/Rab effector complex containing the Sec1 homolog Vps33p is required for homotypic vacuole fusion
DF Seals et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
